The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of bone and liver metastases (BM, LM) in patients with metastatic renal cell carcinoma (mRCC) treated with molecularly targeted agents (MTAs): Results from the International mRCC Database Consortium (IMDC).
Rana R. McKay
No relevant relationships to disclose
Nils Kroeger
No relevant relationships to disclose
Wanling Xie
No relevant relationships to disclose
Jae-Lyun Lee
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose
Georg A. Bjarnason
No relevant relationships to disclose
Mary J. MacKenzie
No relevant relationships to disclose
Lori Wood
No relevant relationships to disclose
Sandy Srinivas
No relevant relationships to disclose
Ulka N. Vaishampayan
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose
Sumanta Kumar Pal
No relevant relationships to disclose
Frede Donskov
No relevant relationships to disclose
Neeraj Agarwal
No relevant relationships to disclose
Srinivas Tantravahi
No relevant relationships to disclose
Brian I. Rini
No relevant relationships to disclose
Daniel Yick Chin Heng
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose